<- Go Home
Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Market Cap
$12.8B
Volume
396.4K
Cash and Equivalents
$497.0M
EBITDA
$563.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.8B
Profit Margin
71.06%
52 Week High
$628.92
52 Week Low
$250.05
Dividend
N/A
Price / Book Value
27.88
Price / Earnings
29.53
Price / Tangible Book Value
-54.07
Enterprise Value
$12.4B
Enterprise Value / EBITDA
20.52
Operating Income
$534.9M
Return on Equity
70.23%
Return on Assets
16.40
Cash and Short Term Investments
$497.0M
Debt
$136.9M
Equity
$459.1M
Revenue
$2.5B
Unlevered FCF
$472.4M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium